Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Response Biomedical (V.RBM) -- Ignore unavailable to you. Want to Upgrade?

To: Dick Martin who wrote (397)	7/23/2001 9:43:33 PM
From: Dick Martin	Read Replies (1) \| Respond to of 655

The stock pick of the week really does not have any new information, a basic restatement of what we already know. About negotiations with partners it says: Bill Radvak, RBM president & CEO says: "This submission to the FDA, based on comprehensive data from our recently completed clinical trials conducted at four sites in the United States, marks the most significant milestone in the Company's history. We fully expect this achievement, & the anticipated clearance by the FDA in three to four months, to significantly enhance our discussions with potential marketing partners." I suspect we will not here anything about a partner until after the FDA approval, but I am glad at least that a little is happening to promote these shares. Regards Dick